The Prostate

Cover image for Vol. 75 Issue 6

Early View (Online Version of Record published before inclusion in an issue)

Edited By: John T. Isaacs

Impact Factor: 3.566

ISI Journal Citation Reports © Ranking: 2013: 10/77 (Urology & Nephrology); 47/124 (Endocrinology & Metabolism)

Online ISSN: 1097-0045

VIEW

  1. 1 - 37
  1. Letters to the Editor

    1. You have full text access to this OnlineOpen article
  2. Original Articles

    1. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells

      Wenhuan Guo, Anne L. Keener, Yifeng Jing, Liquan Cai, Junkui Ai, Jian Zhang, Guohui Fu and Zhou Wang

      Article first published online: 23 MAR 2015 | DOI: 10.1002/pros.22982

    2. You have full text access to this OnlineOpen article
      Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India

      Bushra Ateeq, Lakshmi P. Kunju, Shannon L. Carskadon, Swaroop K. Pandey, Geetika Singh, Immanuel Pradeep, Vini Tandon, Atin Singhai, Apul Goel, Sonal Amit, Asha Agarwal, Amit K. Dinda, Amlesh Seth, Alexander Tsodikov, Arul M. Chinnaiyan and Nallasivam Palanisamy

      Article first published online: 23 MAR 2015 | DOI: 10.1002/pros.22989

    3. You have full text access to this OnlineOpen article
      Prostate cancer marker panel with single cell sensitivity in urine

      Kristen P. Nickens, Amina Ali, Tatiana Scoggin, Shyh-Han Tan, Lakshmi Ravindranath, David G. McLeod, Albert Dobi, David Tacha, Isabell A. Sesterhenn, Shiv Srivastava and Gyorgy Petrovics

      Article first published online: 23 MAR 2015 | DOI: 10.1002/pros.22981

    4. Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy—A 10-year population-based cohort study

      Markus Aly, Robert Dyrdak, Tobias Nordström, Shah Jalal, Caroline E. Weibull, Christian G. Giske and Henrik Grönberg

      Article first published online: 23 MAR 2015 | DOI: 10.1002/pros.22979

    5. Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes

      William T. Berg, Matthew R. Danzig, Jamie S. Pak, Ruslan Korets, Arindam RoyChoudhury, Gregory Hruby, Mitchell C. Benson, James M. McKiernan and Ketan K. Badani

      Article first published online: 21 MAR 2015 | DOI: 10.1002/pros.22992

    6. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer

      Henrique J. Cardoso, Cátia V. Vaz, Sara Correia, Marília I. Figueira, Ricardo Marques, Cláudio J. Maia and Sílvia Socorro

      Article first published online: 18 MAR 2015 | DOI: 10.1002/pros.22976

    7. Malignant cell-derived extracellular vesicles express different chromogranin epitopes compared to prostasomes

      Louise Dubois, Mats Stridsberg, Pedram Kharaziha, Dimitris Chioureas, Niels Meersman, Theocharis Panaretakis and K. Göran Ronquist

      Article first published online: 17 MAR 2015 | DOI: 10.1002/pros.22990

    8. The relationship between prostate-specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate-specific antigen levels

      Kouji Izumi, Hiroko Ikeda, Aerken Maolake, Kazuaki Machioka, Takahiro Nohara, Kazutaka Narimoto, Satoru Ueno, Yoshifumi Kadono, Yasuhide Kitagawa, Hiroyuki Konaka, Atsushi Mizokami and Mikio Namiki

      Article first published online: 8 MAR 2015 | DOI: 10.1002/pros.22985

    9. Methylselenocysteine preventing castration-resistant progression of prostate cancer

      Yanbo Liu, Xichun Liu, Yaxiong Guo, Zuowen Liang, Yong Tian, Lili Lu, Xiaohui Zhao, Ying Sun, Xuejian Zhao, Haitao Zhang and Yan Dong

      Article first published online: 8 MAR 2015 | DOI: 10.1002/pros.22987

    10. Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate

      Xiaolan Fang, Kenneth Gyabaah, Bita Nickkholgh, J. Mark Cline and K.C. Balaji

      Article first published online: 8 MAR 2015 | DOI: 10.1002/pros.22984

    11. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation

      Shu Yang, Jiyuan Zhang, Yalong Zhang, Xuechao Wan, Congzhe Zhang, Xiaohui Huang, Wenhua Huang, Honglei Pu, Chaohan Pei, Hai Wu, Yan Huang, Shengdong Huang and Yao Li

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22977

    12. SLUG is a direct transcriptional repressor of PTEN tumor suppressor

      Berna Uygur, Katrina Abramo, Evgenia Leikina, Calvin Vary, Lucy Liaw and Wen-Shu Wu

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22974

    13. Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study

      Masahito Kido, Masahito Hitosugi, Kanto Ishii, Shuichi Kamimura and Kensuke Joh

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22975

    14. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

      Rebecca E. Graff, Andreas Pettersson, Rosina T. Lis, Natalie DuPre, Kristina M. Jordahl, Elizabeth Nuttall, Jennifer R. Rider, Michelangelo Fiorentino, Howard D. Sesso, Stacey A. Kenfield, Massimo Loda, Edward L. Giovannucci, Bernard Rosner, Paul L. Nguyen, Christopher J. Sweeney, Lorelei A. Mucci and on behalf of the Transdisciplinary Prostate Cancer Partnership ToPCaP

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22973

    15. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation

      Bing Yao, Jinsheng Zhao, Yalin Li, Hui Li, Zhaojun Hu, Pan Pan, Yiran Zhang, E. Du, Ranlu Liu and Yong Xu

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22970

    16. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2

      Mauro Scaravilli, Kati P. Porkka, Anniina Brofeldt, Matti Annala, Teuvo LJ. Tammela, Guido W. Jenster, Matti Nykter and Tapio Visakorpi

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22961

    17. Variant allele of HSD3B1 increases progression to castration-resistant prostate cancer

      Gang Wu, Shengsong Huang, Kent L. Nastiuk, Jinliang Li, Jun Gu, Ming Wu, Qimin Zhang, Hanqing Lin and Denglong Wu

      Article first published online: 1 MAR 2015 | DOI: 10.1002/pros.22967

    18. Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues

      Samira Mousavi, Mojtaba Panjehpour, Mohammad Hossein Izadpanahi and Mahmoud Aghaei

      Article first published online: 20 FEB 2015 | DOI: 10.1002/pros.22955

    19. IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction

      Chong Chen, Qiuyang Zhang, Sen Liu, Keshab R. Parajuli, Yine Qu, Jiandong Mei, Zhiquan Chen, Hui Zhang, Damir B. Khismatullin and Zongbing You

      Article first published online: 14 FEB 2015 | DOI: 10.1002/pros.22971

  3. Original Article

    1. MiR200c targets IRS1 and suppresses prostate cancer cell growth

      Wenjing Su, Miao Xu, Xueqin Chen, Ling Nie, Ni Chen, Jing Gong, Mengni Zhang, Zhengzheng Su, Lei Huang and Qiao Zhou

      Article first published online: 14 FEB 2015 | DOI: 10.1002/pros.22968

  4. Original Articles

    1. You have full text access to this OnlineOpen article
      Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America

      Anthony M. Joshua, Neal D. Shore, Fred Saad, Kim N. Chi, Carl A. Olsson, Urban Emmenegger, Mark Scholz, William Berry, Som D. Mukherjee, Eric Winquist, Naomi B. Haas, Margaret A. Foley, Carl Dmuchowski, Frank Perabo, Mohammad Hirmand, Nahla Hasabou, Dana Rathkopf and for The Enzalutamide Expanded Access Study Investigators

      Article first published online: 14 FEB 2015 | DOI: 10.1002/pros.22965

    2. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia

      Sophie Bernichtein, Natascha Pigat, Philippe Camparo, Alain Latil, Mélanie Viltard, Gérard Friedlander and Vincent Goffin

      Article first published online: 14 FEB 2015 | DOI: 10.1002/pros.22953

    3. Prostate cancer screening using risk stratification based on a multi-state model of genetic variants

      Amy Ming-Fang Yen, Anssi Auvinen, Johanna Schleutker, Yi-Ying Wu, Jean Ching-Yuan Fann, Teuvo Tammela, Sam Li-Sheng Chen, Sherry Yueh-Hsia Chiu and Hsiu-Hsi Chen

      Article first published online: 14 FEB 2015 | DOI: 10.1002/pros.22964

    4. You have full text access to this OnlineOpen article
      Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo

      Jan Kroon, Jeroen T. Buijs, Geertje van der Horst, Henry Cheung, Maaike van der Mark, Louis van Bloois, Larissa Y. Rizzo, Twan Lammers, Rob C. Pelger, Gert Storm, Gabri van der Pluijm and Josbert M. Metselaar

      Article first published online: 8 FEB 2015 | DOI: 10.1002/pros.22963

  5. Original Article

    1. A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel

      Osamu Ukimura, Mitchell E Gross, Andre Luis de Castro Abreu, Raed A. Azhar, Toru Matsugasumi, So Ushijima, Motohiro Kanazawa, Manju Aron and Inderbir S. Gill

      Article first published online: 8 FEB 2015 | DOI: 10.1002/pros.22969

  6. Original Articles

    1. Bone marrow-derived cells contribute to regeneration of injured prostate epithelium and stroma

      Wataru Nakata, Yasutomo Nakai, Takahiro Yoshida, Mototaka Sato, Koji Hatano, Akira Nagahara, Kazutoshi Fujita, Motohide Uemura and Norio Nonomura

      Article first published online: 8 FEB 2015 | DOI: 10.1002/pros.22962

    2. You have full text access to this OnlineOpen article
      Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations

      Haibo Liu, Radu M. Cadaneanu, Kevin Lai, Baohui Zhang, Lihong Huo, Dong Sun An, Xinmin Li, Michael S. Lewis and Isla P. Garraway

      Article first published online: 7 FEB 2015 | DOI: 10.1002/pros.22959

    3. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer

      Suyin Paulynn Chin, James R. Marthick, Alison C. West, Annabel K. Short, Jyoti Chuckowree, Andrea M. Polanowski, Russell J. Thomson, Adele F. Holloway and Joanne L. Dickinson

      Article first published online: 7 FEB 2015 | DOI: 10.1002/pros.22954

    4. γ-oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines

      Gabriela E. Hirsch, Mariana M. Parisi, Leo A.M. Martins, Claudia M.B. Andrade, Florencia M. Barbé-Tuana and Fátima T.C.R. Guma

      Article first published online: 25 JAN 2015 | DOI: 10.1002/pros.22960

    5. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999–2008

      Michael B. Cook, Philip S. Rosenberg, Frances A. McCarty, Manxia. Wu, Jessica King, Christie Eheman and William F. Anderson

      Article first published online: 25 JAN 2015 | DOI: 10.1002/pros.22958

    6. The effect of Pomegranate Fruit Extract on testosterone-induced BPH in rats

      Amr E. Ammar, Ahmed Esmat, Mohammed D.H. Hassona, Mariane G. Tadros, Ashraf B. Abdel-Naim and Emma S. Tomlinson Guns

      Article first published online: 25 JAN 2015 | DOI: 10.1002/pros.22951

    7. Prostate-specific membrane antigen-based imaging in prostate cancer: Impact on clinical decision making process

      Mehmet Onur Demirkol, Ömer Acar, Burcu Uçar, Sultan Rana Ramazanoğlu, Yeşim Sağlıcan and Tarık Esen

      Article first published online: 18 JAN 2015 | DOI: 10.1002/pros.22956

    8. Prostate atypia: Does repeat biopsy detect clinically significant prostate cancer?

      Ryan P. Dorin, Scott Wiener, Cory D. Harris and Joseph R. Wagner

      Article first published online: 16 JAN 2015 | DOI: 10.1002/pros.22950

VIEW

  1. 1 - 37

SEARCH

SEARCH BY CITATION